+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fundamental and clinical studies of ceftazidime in the field of obstetrics and gynecology



Fundamental and clinical studies of ceftazidime in the field of obstetrics and gynecology



Japanese Journal of Antibiotics 37(1): 28-32



Ceftazidime ( CAZ ), a new cephalosporin antibiotic, was fundamentally and clinically studied. The following results were obtained. Serum and internal genital tissue levels of CAZ were measured following intravenous drip infusion of 1 g for 30 minutes. Serum levels of more than 10 micrograms/ml and tissue levels of more than about 7 micrograms/ml were maintained after 2 hours to 2 hours and 30 minutes, respectively. Favourable transfer of CAZ into the pelvic dead space exudate was observed. The exudate level attained its peak of 31.54 micrograms/ml on average at 2 hours and was 16.8 micrograms/ml on average even at 8 hours after intravenous drip infusion. A total of 6 cases comprising 1 of adnexitis, 2 of pyometra, 1 of endometritis and 2 of parametritis was treated with CAZ at a dose of 0.5 approximately 2.0 g twice daily by intravenous injection or intravenous drip infusion. The clinical response was excellent in 1 case, good in 4 cases and poor in 1 case. Abnormal laboratory findings and side effects due to the drug were not noted.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043166454

Download citation: RISBibTeXText

PMID: 6374196


Related references

Fundamental and clinical studies on ceftazidime in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 37(1): 23-27, 1984

Experimental and clinical studies of ceftazidime in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 36(12): 3491-3506, 1983

Basic and clinical studies on ceftazidime in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 36(12): 3463-3475, 1983

Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 35(9): 2195-2199, 1982

Fundamental and clinical studies of piperacillin in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 35(9): 2200-2205, 1982

Fundamental and clinical studies of aztreonam in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 38(12): 3645-3650, 1985

Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 37(12): 2328-2337, 1984

Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 38(12): 3591-3598, 1985

Fundamental and clinical studies on cefamandole in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 33(4): 416-426, 1980

Fundamental and clinical studies on cefotaxime in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 34(4): 515-520, 1981

Fundamental and clinical studies on cefuzonam in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 40(5): 1074-1083, 1987

Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 37(12): 2364-2370, 1984

Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 38(4): 1011-1016, 1985

Fundamental and clinical studies of cefpiramide in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 38(8): 2360-2366, 1985

Fundamental and clinical studies on cefpiramide in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 38(8): 2379-2383, 1985